Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 9Hyperandrogenism 4Neoplasms 3Skin Diseases 1Sarcoma 1Rare Diseases 1Obesity 1Metabolic Syndrome 1Lymphoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hematologic Neoplasms 1Heart Failure 1Glioblastoma 1Endocrine System Diseases 1Critical Illness 1Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1Advanced Malignant Neoplasm 1Acute Kidney Injury 1Acanthosis Nigricans 1

Interventions

sodium sulfate 1Stents 1Spironolactone 1Renal Dialysis 1Plasma Exchange 1Nephrotomy 1Nephrostomy, Percutaneous 1Ischemic Preconditioning 1Hypothermia, Induced 1Hemodiafiltration 1Drug Therapy 1Cisplatin 1Cilastatin 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acute Kidney Injury × Spironolactone × Clear all
NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown
24 enrolled
Genitourinary

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡